Antihyperglycemic effect of oolong tea in type 2 diabetes.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 12766099.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To determine the efficacy of oolong tea for lowering plasma glucose in type 2 diabetic patients in Miaoli, Taiwan. A total of 20 free-living subjects who had type 2 diabetes and took hyperglycemic drugs as prescribed were enrolled in the present study. Subjects consumed oolong tea (1,500 ml) or water for 30 days each in a randomized crossover design. Tea was not consumed for 14 days prior to treatments. Relative to initial concentrations, oolong tea markedly lowered concentrations of plasma glucose (from 229 +/- 53.9 to 162.2 +/- 29.7 mg/dl, P < 0.001) and fructosamine (from 409.9 +/- 96.1 to 323.3 +/- 56.4 micromol/l, P < 0.01), whereas the water control group had not changed (208.7 +/- 61.0 vs. 232.3 +/- 63.1 mg/dl for glucose and from 368.4 +/- 85.0 to 340.0 +/- 76.1 micromol/l for fructosamine). Oolong tea may be an effective adjunct to oral hypoglycemic agents in the treatment of type 2 diabetes.
Medical subject headings
- Blood Glucose
- Diabetes Mellitus, Type 2
- Dietary Supplements
- Hypoglycemic Agents
- Tea